Skip to main content
Erschienen in: Intensive Care Medicine 9/2018

26.12.2017 | What's New in Intensive Care

What’s new in ICU in 2050: big data and machine learning

verfasst von: Sébastien Bailly, Geert Meyfroidt, Jean-François Timsit

Erschienen in: Intensive Care Medicine | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Excerpt

The amount of digitalized data that the world produces today is by all measures unseen and spectacular. Social media, e-commerce, and the Internet of things generate approximately 2.5 quintillions of bytes per day, an amount that equals 100 million Blu-ray discs, or almost 30,000 GB per second. Data grows exponentially, and 90% of all data on the Internet has been created since 2016. This trend will continue in the next decades [1]. Such datasets of unimaginable size cannot be maintained with traditional database management technology, or examined with traditional statistical techniques. The general term for methods to manage and analyze such unstructured datasets is “big data”. Although the term is often ill-defined and improperly used, the five “Vs” concept is a good summary: Volume, Velocity, Variety, Veracity, and Value referring to, respectively, the large quantity of data; the speed of acquisition; the diversity of data sources; the uncertain data quality; and the possible valorization. The last of these is without a doubt the “V” that matters most. In medicine, the first datasets amenable to big data were generated when techniques to process genomic data became available, for instance for tumor genotyping in oncology [2]. …
Literatur
1.
Zurück zum Zitat Ffoulkes P (2017) InsideBIGDATA guide to the intelligent use of big data on an industrial scale. InsideBIGDATA, Massachusetts Ffoulkes P (2017) InsideBIGDATA guide to the intelligent use of big data on an industrial scale. InsideBIGDATA, Massachusetts
2.
Zurück zum Zitat Booth CM, Tannock IF (2014) Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110:551–555CrossRefPubMedPubMedCentral Booth CM, Tannock IF (2014) Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110:551–555CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Apkon M, Singhaviranon P (2001) Impact of an electronic information system on physician workflow and data collection in the intensive care unit. Intensive Care Med 27:122–130CrossRefPubMed Apkon M, Singhaviranon P (2001) Impact of an electronic information system on physician workflow and data collection in the intensive care unit. Intensive Care Med 27:122–130CrossRefPubMed
5.
Zurück zum Zitat Murdoch TB, Detsky AS (2013) The inevitable application of big data to health care. JAMA 309:1351–1352CrossRefPubMed Murdoch TB, Detsky AS (2013) The inevitable application of big data to health care. JAMA 309:1351–1352CrossRefPubMed
6.
Zurück zum Zitat Flechet M, Grandas FG, Meyfroidt G (2016) Informatics in neurocritical care: new ideas for Big Data. Curr Opin Crit Care 22:87–93PubMed Flechet M, Grandas FG, Meyfroidt G (2016) Informatics in neurocritical care: new ideas for Big Data. Curr Opin Crit Care 22:87–93PubMed
7.
Zurück zum Zitat Simpkin AL, Schwartzstein RM (2016) Tolerating uncertainty—the next medical revolution? N Engl J Med 375:1713–1715CrossRefPubMed Simpkin AL, Schwartzstein RM (2016) Tolerating uncertainty—the next medical revolution? N Engl J Med 375:1713–1715CrossRefPubMed
8.
Zurück zum Zitat Angus DC (2015) Fusing randomized trials with big data: the key to self-learning health care systems? JAMA 314:767–768CrossRefPubMed Angus DC (2015) Fusing randomized trials with big data: the key to self-learning health care systems? JAMA 314:767–768CrossRefPubMed
9.
Zurück zum Zitat Mirnezami R, Nicholson J, Darzi A (2012) Preparing for precision medicine. N Engl J Med 366:489–491CrossRefPubMed Mirnezami R, Nicholson J, Darzi A (2012) Preparing for precision medicine. N Engl J Med 366:489–491CrossRefPubMed
10.
Zurück zum Zitat Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M (2017) The intensive care medicine research agenda on septic shock. Intensive Care Med 43:1294–1305 Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M (2017) The intensive care medicine research agenda on septic shock. Intensive Care Med 43:1294–1305
11.
Zurück zum Zitat Robins JM, Hernan MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11:550–560CrossRefPubMed Robins JM, Hernan MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11:550–560CrossRefPubMed
12.
Zurück zum Zitat Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF (2015) Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med 191:1139–1146CrossRefPubMed Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF (2015) Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med 191:1139–1146CrossRefPubMed
13.
Zurück zum Zitat Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, EMPIRICUS Trial Group (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555–1564CrossRefPubMed Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, EMPIRICUS Trial Group (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555–1564CrossRefPubMed
14.
Zurück zum Zitat Guiza F, Van Eyck J, Meyfroidt G (2013) Predictive data mining on monitoring data from the intensive care unit. J Clin Monit Comput 27:449–453CrossRefPubMed Guiza F, Van Eyck J, Meyfroidt G (2013) Predictive data mining on monitoring data from the intensive care unit. J Clin Monit Comput 27:449–453CrossRefPubMed
15.
Zurück zum Zitat Flechet M, Guiza F, Schetz M, Wouters P, Vanhorebeek I, Derese I, Gunst J, Spriet I, Casaer M, Van den Berghe G, Meyfroidt G (2017) AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin. Intensive Care Med 43:764–773CrossRefPubMed Flechet M, Guiza F, Schetz M, Wouters P, Vanhorebeek I, Derese I, Gunst J, Spriet I, Casaer M, Van den Berghe G, Meyfroidt G (2017) AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin. Intensive Care Med 43:764–773CrossRefPubMed
16.
17.
Metadaten
Titel
What’s new in ICU in 2050: big data and machine learning
verfasst von
Sébastien Bailly
Geert Meyfroidt
Jean-François Timsit
Publikationsdatum
26.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 9/2018
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-017-5034-3

Weitere Artikel der Ausgabe 9/2018

Intensive Care Medicine 9/2018 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.